Proton Beam Therapy for Chondrosarcoma

Chondrosarcoma

A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma Phase I Study of IGM-8444 as a Single Agent and in Combination in Subjects With Relapsed and/or Refractory Solid Cancers Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma – Phase 1b Trial Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull Base A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas Proton Beam Therapy for Chondrosarcoma Low Grade Chondrosarcoma Versus Enchondroma AG-120 in People With IDH1 Mutant Chondrosarcoma Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma